FHIR IG analytics| Package | hl7.fhir.us.uscdi-scd |
| Resource Type | ValueSet |
| Id | ValueSet-scd-medication-vs.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/hlnconsulting/uscdi-scd-ig/ValueSet-scd-medication-vs.html |
| URL | http://hl7.org/fhir/us/uscdi-scd/ValueSet/scd-medication-vs |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-09-11T00:10:30+00:00 |
| Name | SCDMedicationVS |
| Title | SCD Medication Value Set |
| Realm | us |
| Authority | hl7 |
| Description | Value set of RxNorm codes for medications used in Sickle Cell Disease management, including disease-modifying therapies, iron chelation agents, and prophylactic antibiotics. TODO: Confirm RxNorm concept IDs (placeholders marked with comments). Submit to VSAC for OID assignment and curated maintenance. |
| Copyright | RxNorm is in the public domain (NLM). |
No resources found
| CodeSystem | ||
| hl7.terminology.r4b#6.0.2 | rxnorm | RxNorm |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet scd-medication-vs
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)| Code | Display |
| 202462 | hydroxyurea |
| 1876366 | L-glutamine oral powder |
| 2002016 | crizanlizumab |
| 2200647 | voxelotor |
| 214385 | deferasirox |
| 3271 | deferoxamine |
| 72398 | deferiprone |
| 7980 | penicillin V |
| 723 | amoxicillin |
| 4511 | folic acid |
{
"resourceType": "ValueSet",
"id": "scd-medication-vs",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://hl7.org/fhir/us/uscdi-scd/ValueSet/scd-medication-vs",
"version": "0.1.0",
"name": "SCDMedicationVS",
"title": "SCD Medication Value Set",
"status": "active",
"experimental": false,
"date": "2026-09-11T00:10:30+00:00",
"publisher": "HL7 International / Public Health",
"contact": [
{
"name": "HL7 International / Public Health",
"telecom": [
{
"system": "url",
"value": "https://www.hl7.org/Special/committees/pher"
},
{
"system": "email",
"value": "pher@lists.HL7.org"
}
]
},
{
"name": "HL7 Public Health Work Group",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/pher"
},
{
"system": "email",
"value": "pher@lists.HL7.org"
}
]
}
],
"description": "Value set of RxNorm codes for medications used in Sickle Cell Disease\nmanagement, including disease-modifying therapies, iron chelation agents,\nand prophylactic antibiotics.\n\nTODO: Confirm RxNorm concept IDs (placeholders marked with comments).\nSubmit to VSAC for OID assignment and curated maintenance.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US",
"display": "United States of America"
}
]
}
],
"copyright": "RxNorm is in the public domain (NLM).",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "202462",
"display": "hydroxyurea"
},
{
"code": "1876366",
"display": "L-glutamine oral powder"
},
{
"code": "2002016",
"display": "crizanlizumab"
},
{
"code": "2200647",
"display": "voxelotor"
},
{
"code": "214385",
"display": "deferasirox"
},
{
"code": "3271",
"display": "deferoxamine"
},
{
"code": "72398",
"display": "deferiprone"
},
{
"code": "7980",
"display": "penicillin V"
},
{
"code": "723",
"display": "amoxicillin"
},
{
"code": "4511",
"display": "folic acid"
}
]
}
]
}
}